000868439 001__ 868439
000868439 005__ 20210130004219.0
000868439 0247_ $$2doi$$a10.1093/neuonc/noz236
000868439 0247_ $$2ISSN$$a1522-8517
000868439 0247_ $$2ISSN$$a1523-5866
000868439 0247_ $$2Handle$$a2128/24497
000868439 0247_ $$2altmetric$$aaltmetric:73085917
000868439 0247_ $$2pmid$$apmid:31859354
000868439 0247_ $$2WOS$$aWOS:000522636300005
000868439 037__ $$aFZJ-2020-00033
000868439 082__ $$a610
000868439 1001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b0$$eCorresponding author$$ufzj
000868439 245__ $$aCombined FET PET/ADC mapping: improved imaging of glioma infiltration?
000868439 260__ $$aOxford$$bOxford Univ. Press$$c2020
000868439 3367_ $$2DRIVER$$aarticle
000868439 3367_ $$2DataCite$$aOutput Types/Journal article
000868439 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1583498637_27455
000868439 3367_ $$2BibTeX$$aARTICLE
000868439 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000868439 3367_ $$00$$2EndNote$$aJournal Article
000868439 520__ $$aConventional MRI is the method of choice for the diagnosis of cerebral gliomas owing to its ability to detect structural changes with high spatial resolution and outstanding sensitivity. In malignant gliomas, the determination of tumor extent is primarily based on the assessment of blood–brain barrier (BBB) disruption as reflected by contrast enhancement after application of paramagnetic contrast media. In gliomas of World Health Organization (WHO) grades II and III, which are frequently non-enhancing, estimation of tumor extent relies on signal abnormalities in T2-weighted MRI or in the fluid-attenuated inversion recovery (FLAIR) sequence. It is well known, however, that neither contrast enhancement nor FLAIR abnormalities are specific for neoplastic tissue....
000868439 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000868439 588__ $$aDataset connected to CrossRef
000868439 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b1$$ufzj
000868439 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b2$$ufzj
000868439 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noz236$$gp. noz236$$n3$$p313-314$$tNeuro-Oncology$$v22$$x1523-5866$$y2020
000868439 8564_ $$uhttps://juser.fz-juelich.de/record/868439/files/Langen_Post%20Print_2019_Neuro-Oncol_Combined%20PET%20PET_ADC%20mapping.pdf$$yPublished on 2019-12-20. Available in OpenAccess from 2020-12-20.
000868439 8564_ $$uhttps://juser.fz-juelich.de/record/868439/files/noz236.pdf$$yRestricted
000868439 8564_ $$uhttps://juser.fz-juelich.de/record/868439/files/Langen_Post%20Print_2019_Neuro-Oncol_Combined%20PET%20PET_ADC%20mapping.pdf?subformat=pdfa$$xpdfa$$yPublished on 2019-12-20. Available in OpenAccess from 2020-12-20.
000868439 8564_ $$uhttps://juser.fz-juelich.de/record/868439/files/noz236.pdf?subformat=pdfa$$xpdfa$$yRestricted
000868439 909CO $$ooai:juser.fz-juelich.de:868439$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000868439 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b0$$kFZJ
000868439 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b1$$kFZJ
000868439 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b2$$kFZJ
000868439 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000868439 9141_ $$y2020
000868439 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000868439 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000868439 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2017
000868439 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000868439 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000868439 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000868439 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEURO-ONCOLOGY : 2017
000868439 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000868439 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000868439 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000868439 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000868439 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000868439 920__ $$lyes
000868439 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000868439 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000868439 980__ $$ajournal
000868439 980__ $$aVDB
000868439 980__ $$aUNRESTRICTED
000868439 980__ $$aI:(DE-Juel1)INM-3-20090406
000868439 980__ $$aI:(DE-Juel1)INM-4-20090406
000868439 9801_ $$aFullTexts